{"id":1162806,"title":"DSEN Abstract: Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T21:41:30.030000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/53213.html","snippet":"DSEN Abstract Hepatitis C Treatments: Contribution of Patient Genetics in Sofosbuvir Treatment Failure Despite low rates of sofosbuvir failure in the pivotal clinical trials (2 - 4%), this real-world trial shows a higher failure rate of 9.5%. This study also found that patients…","rawSnapshotUrl":"/api/snapshots/raw/1162806","browseUrl":"https://replay.healtharchive.ca/job-8/20260411214130/https://cihr-irsc.gc.ca/e/53213.html#ha_snapshot=1162806","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}